Product Highlights

Composition	Glimepiride IP 2 mg & Metformin Hydrochloride IP 500 mg
Form	Sustained Release Tablet
Packaging Size	10x10
Manufacturer	Nepal Pharmaceuticals Laboratory Pvt. Ltd.
Brand Name	Formin-G2

Description

Formin-G2 Tablets, produced by Nepal Pharmaceuticals Laboratory Pvt. Ltd., contain a combination of Glimepiride IP (2 mg) and Metformin Hydrochloride IP (500 mg) per tablet.
Glimepiride is a sulfonylurea medication prescribed for managing type 2 diabetes by stimulating insulin release from the pancreas.
Metformin Hydrochloride is a biguanide medication that improves insulin sensitivity and reduces glucose production in the liver, aiding in the control of blood sugar levels.
The combination of Glimepiride and Metformin Hydrochloride in Formin-G2 Tablets offers complementary mechanisms of action for better glycemic control in diabetic patients.

About Supplier

We Specialize in an array of brands, our extensive inventory includes medicines and medical instruments, ensuring comprehensive solutions for healthcare professionals and individuals alike. Committed to excellence, we prioritize quality and reliability, offering a curated selection of products meticulously sourced from trusted manufacturers. Our dedication to customer satisfaction drives us to provide personalized service, tailored to meet unique requirements. With a steadfast commitment to advancing healthcare accessibility and efficacy, Concept Medi Concern Company stands as a steadfast ally in promoting well-being and fostering a healthier community.